scispace - formally typeset
Search or ask a question

Showing papers by "Zygmunt Kazimierczuk published in 2012"


Journal ArticleDOI
TL;DR: By direct comparison of two CK2-directed cargos, the data provide proof that the TBG encapsulation design for delivery of drugs specifically to cancer cells has strong potential for small molecule- and nucleic acid-based cancer therapy.

35 citations


Journal ArticleDOI
TL;DR: Four novel tetrahalogenobenzimidazoles and their newly obtained N(1)- and 2-S-carboxyalkyl derivatives showed potent inhibitory activity against individual catalytic subunits of human CK2.

29 citations


Journal ArticleDOI
TL;DR: There was no clear correlation between cell viability and apoptosis induction indicating additional cell death mechanisms, and the determination of the LD(50) value identified the 2-aminoethylamino-4,5,6,7-tetraiodobenzimidazole with an additional methyl group at position 1 (6) as the most efficient compound.

16 citations


Journal ArticleDOI
TL;DR: From among all salts studied, only for (S)-2,3,4,5,6-pentabromobenzylisothiouronium chloride are both nitrogen sites equivalent, which has been explained by the slow exchange.
Abstract: Isothioureas, inhibitors of nitric oxide synthases, have been studied experimentally in solid state by nuclear quadrupole double resonance (NQDR) and X-ray methods and theoretically by the quantum theory of atoms in molecules/density functional theory. Resonance frequencies on 14N have been detected and assigned to particular nitrogen sites in each molecule. The crystal packings of (S)-3,4-dichlorobenzyl-N-methylisothiouronium chloride with the disordered chlorine positions in benzene ring and (S)-butyloisothiouronium bromide have been resolved in X-ray diffraction studies. 14N NQDR spectra have been found good indicators of isomer type and strength of intra- or intermolecular N–H···X (X = Cl, Br) interactions. From among all salts studied, only for (S)-2,3,4,5,6-pentabromobenzylisothiouronium chloride are both nitrogen sites equivalent, which has been explained by the slow exchange. This unique structural feature can be a key factor in the high biological activity of (S)-2,3,4,5,6-pentabromobenzylisothio...

12 citations


Journal ArticleDOI
TL;DR: The ZKKs were found to induce apoptosis in HL-60 and K-562 cell lines in a concentration-dependent manner at low micromolar concentrations and show promise for their study as new compounds in the treatment of leukemia, after an appropriate preclinical toxicity profile.
Abstract: A series of new pentabromobenzylisothioureas [ZKK-1–ZKK-5; (ZKKs)] carrying additional substituents on nitrogen atoms has been synthesized. The ZKKs were found to induce apoptosis in HL-60 (human promyleocytic leukemia) and K-562 (human chronic erythromyeloblastoid leukemia) cell lines in a concentration-dependent manner at low micromolar concentrations. ZKK-3 [(N,N′-dimethyl-S-2,3,4,5,6-pentabromobenzyl)isothiouronium bromide] showed the highest proapoptotic activity in HL-60 cells, whereas ZKK-2 [N-methyl-S-(2,3,4,5,6-pentabromobenzyl)isothiouronium bromide] was most effective in this respect in K-562 cells. During the ZKKs-induced apoptosis, an 85 kDa fragment of cleaved PARP (caspase-3 and caspase-7 substrate) was detected in both cell lines tested. The studied compounds also decreased mitochondrial transmembrane potential in both these cell lines and caused the cells to accumulate in G1 and at the G1/S border of the cell cycle in a concentration-dependent manner. These results show promise for their study as new compounds in the treatment of leukemia, after an appropriate preclinical toxicity profile.

8 citations


Journal Article
TL;DR: A number of novel N- and N,N'-substituted S-2,3,4,5,6-pentabromobenzylisothiouronium bromides are synthesised and their activity against the human prostate adenocarcinoma PC3 cell line and a synergic proapoptotic effect with the new casein kinase II inhibitor is shown.
Abstract: Prostate cancer is the second most common cancer in elderly men worldwide and its incidence rate is rising continuously. Agents capable of inducing apoptosis in prostate cancer cells seem a promising approach to treat this malignancy. In this study we describe the synthesis of a number of novel N- and N,N'-substituted S-2,3,4,5,6-pentabromobenzylisothiouronium bromides and their activity against the human prostate adenocarcinoma PC3 cell line. All the compounds produced changes in mitochondrial transmembrane potential and cell cycle progression, showed a cytostatic effect and induced apoptosis in the tested cancer line in a concentration- and time-dependent manner. The most effective compounds ZKK-3, ZKK-9 and ZKK-13 produced, at 20 microM concentration, apoptosis in 42, 46, and 66% of the cells, respectively, after 48 h incubation. Two selected S-2,3,4,5,6-pentabromobenzylisothiouronium bromides (ZKK-3, ZKK-9) showed also a synergic proapoptotic effect with the new casein kinase II inhibitor 2-(4-methylpiperazin-1-yl)-4,5,6,7-tetrabromo-1H-benzimidazole (TBIPIP) in the PC3 cell line.

7 citations


Journal ArticleDOI
TL;DR: A series of new polyhalogenated benzimidazoles have been synthesized and their antibacterial and antiprotozoal activity was evaluated as mentioned in this paper and the most potent agents against bacteria and fungi were 4,5,6,7,tetrachlorobenzimiddrugs with polyfluoroalkyl chain at position 2 of the heterocyclus.

6 citations